Risk, its perception and the media: the MMR controversy

By Hackett Alison Jane  

Community Practitioner, Vol. 81, Iss. 7, 2008-07 ,pp. : 22-25

Community Practitioner

Access to resources Recommend Favorite

Health risk communication and amplification: learning from the MMR vaccination controversy

By Petts Judith   Niemeyer Simon  

Health, Risk & Society, Vol. 6, Iss. 1, 2004-03 ,pp. : 7-23

Routledge Ltd

Access to resources Recommend Favorite

All the postgenomic world is a stage: the actors and narrators required for translating pharmacogenomics into public health

By Dove Edward S   Özdemir Vural  

Personalized Medicine, Vol. 10, Iss. 3, 2013-05 ,pp. : 213-216

Future Medicine

Access to resources Recommend Favorite

Autoantibodies in Atrial Fibrillation: Actors, Biomarkers or Bystanders? How Far Have We Come?

By  

Cardiology, Vol. 112, Iss. 3, 2008-07 ,pp. : 178-179

Karger

Access to resources Recommend Favorite

New risk or old risk, high risk or no risk? How scientists' standpoints shape their nanotechnology risk frames

By Powell Maria C.  

Health, Risk & Society, Vol. 9, Iss. 2, 2007-06 ,pp. : 173-190

Routledge Ltd

Access to resources Recommend Favorite